Cannabis Strategic Ventures, Inc. (NUGS) Aims to Clear

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
406
Cannabis Strategic Ventures, Inc. (NUGS) Aims to Clear Higher Hurdle in Reporting Standards

- Completion of full audit for fiscal year ended March 31, 2018
- Close of three-year audit required to become fully reporting company with SEC
- Plans afoot to uplist to a higher OTC Markets tier

Cannabis Strategic Ventures, Inc. (OTC: NUGS) wants to be an open book. The company has announced the completion of a full audit for its fiscal year ended March 31, 2018. This marks the close of the three-year audit required as a condition of becoming a fully reporting company with the U.S. Securities & Exchange Commission (SEC). Cannabis Strategic Ventures will utilize the audit results to file future reports and disclosures with the SEC and move the company to fully reporting status. The company will also use the fully reporting status to uplist to a higher OTC Markets tier (http://nnw.fm/i8Swy).

The OTC Markets in some ways resemble traditional debutante balls, for they allow investors an introductory look at public companies by publicizing information about the companies and their securities prices. A company that wants to appear on an OTC Market – OTCQX, OTCQB or Pink – must get its securities to be the subject of broker-dealer quotes on OTC Link ATS. To quote a company’s securities, a broker-dealer must seek approval from the Financial Industry Regulatory Authority (FINRA) by submitting a Form 211. Unlike on the senior stock exchanges, such as the NYSE or the Nasdaq, OTC companies do not list their own stock for trading. Rather, the securities are quoted on OTC Link ATS. Consequently, securities appearing on the OTC platforms are, strictly speaking, “quoted” not “listed.” Moreover, securities quoted on the OTCQX, OTCQB and Pink markets may trade without being registered with the SEC.

Being “quoted” is, typically, the first step toward being “listed,” which offers many advantages for a company’s securities, including better price determination and increased liquidity. Holders of the securities also benefit from increased information about the company, which becomes mandatory, as well as access to an orderly marketplace, the reassurance of regulatory oversight and the availability of trading information and pricing. As it heads for fully reporting status, NUGS’ securities are set to benefit from this increased transparency.

The company, based in Los Angeles, California, focuses on supporting entrepreneurial growth within the fast-growing legal cannabis sector, and it has embarked on a number of ventures that align with that initiative. Together with True Promise Beauty, the company will be developing a new line of cannabidiol (CBD)-based luxury skin and hair care products – LYXR – from ingredients like hemp-derived phytocannabinoids and other natural components (http://nnw.fm/O6hXu).

Additionally, Cannabis Strategic Ventures recently announced its acquisition of The Asher House Pet CBD brand, a line of U.S. hemp-derived cannabidiol (CBD) supplements for pets, which targets a market vertical that’s becoming increasingly popular (http://nnw.fm/p4hnY). The company also acquired the hemp-based brand Fitamins CBD, which provided a line of vitamin and hemp-derived CBD products that will be distributed through a network of 600+ wholesalers serving the Asian-American market (http://nnw.fm/K8SeC).

Cannabis Strategic Ventures also offers bespoke personnel solutions to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. Earlier this year, it announced a definitive agreement to acquire all issued and authorized shares of Worldwide Staffing Group, Inc. (Worldwide). The acquisition is expected to boost revenues substantially. For 2017, Worldwide’s revenues were approximately $1.5 million (http://nnw.fm/lD0JI).

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Cannabis Strategic Ventures, Inc (NUGS) Stock Research Links

NUGS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 43

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

CompoSecure's Adam Lowe Executes $490K Stock Sale and Insights

Updated Category News Views 302

Adam Lowe's Notable Stock Transactions Revealed Adam Lowe, the Chief Product & Innovation Officer at CompoSecure, Inc. (NASDAQ: CMPO), has recently stirred up some buzz following his stock sales, which amounted to over $490,000. According to recent regulatory filings, on a pivotal day, Lowe sold 40,658 shares of CompoSecure's Class A Common Stock, netting him $490,335...

Continue Reading
Extendicare Reports Strong Q4 and Year-End Results with Dividend Boost

Updated Category News Views 299

Extendicare's Positive Financial Performance in Q4 2024 Extendicare Inc. (TSX: EXE) has released its results for the last quarter of 2024, showcasing significant growth and a successful year overall. The company, known for its commitment to quality care for seniors across Canada, reported a remarkable increase in adjusted EBITDA, a key indicator of financial performance,...

Continue Reading
The Kayon's New Villas: Ubud's Intimate Luxury Retreat

Updated Category News Views 10

Embracing Exclusive Escapes in Ubud A couple of days ago, The Kayon Resort decided to stir the pot in Ubud's luxury accommodation landscape by rolling out two swanky villa categories: the Premier Pool Villa and the Royal Jacuzzi Pool Villa. No pandering here, just straight-up elegance mingling with nature. Why Ubud's Going Gaga Over Privacy People are craving privacy and...

Continue Reading
Exploring the Vibrant Growth of the Outdoor Backpacks Market

Updated Category News Views 147

The Outdoor Backpacks Market Growth Story The Outdoor Backpacks Market is experiencing remarkable growth, expected to increase by USD 997.1 million between 2025 and 2029. This growth reflects a projected CAGR of approximately 5.4%, driven primarily by rising interest in hiking among millennials. Today's outdoor enthusiasts are not just looking for gear; they desire...

Continue Reading
Nuveen Closed-End Funds Share Updated Distribution Notices

Updated Category News Views 79

Nuveen stirred the pot back in 2024 with a fresh drop on their closed-end funds (CEFs), rolling out distribution notices that laid bare the guts of their quarterly payouts. Yeah, those notices were packed with juicy details about where investors' cash was coming from—like net investment income and capital gains—but they also signaled some unsettling shifts lurking...

Continue Reading